Skip to content
10-K

Annual Report

Panacea Life Sciences Holdings, Inc. PLSH

0001493152-23-009742

← back to feed
Filed
Mar 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 15, 2023 14.76M sh
Capex FY 2022 · Dec 31, 2021 $162.95K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$3.92M
Cash And Equivalents FY 2022 · Dec 31, 2021 $19.77K
Stockholders Equity FY 2022 · Dec 31, 2021 $7.1M
Current Liabilities FY 2022 · Dec 31, 2021 $10.07M
Total Liabilities FY 2022 · Dec 31, 2021 $16.68M
Current Assets FY 2022 · Dec 31, 2021 $9.1M
Total Assets FY 2022 · Dec 31, 2021 $23.78M
Eps Basic FY 2022 · Dec 31, 2021 −$0.28
Sga Expense FY 2022 · Dec 31, 2021 $1.52M
Net Income FY 2022 · Dec 31, 2021 −$4.78M
Operating Income FY 2022 · Dec 31, 2021 −$5.94M
Gross Profit FY 2022 · Dec 31, 2021 $540.58K
Cost Of Revenue FY 2022 · Dec 31, 2021 $1.52M
Revenue FY 2022 · Dec 31, 2021 $2.06M